Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shigehisa Kitano

Showing results (41-50 of 150) with videos related to

Pageof 15
Sort By:
British Journal of Cancer|November 26, 2019
Relationship between the immune microenvironment of different locations in a primary tumour and clinical outcomes of oesophageal squamous cell carcinomaKen Hatogai, Satoshi Fujii, Shigehisa Kitano, et al.
International Journal of Hematology|October 24, 2019
Impact of low-dose anti-thymocyte globulin on immune reconstitution after allogeneic hematopoietic cell transplantationAyumu Ito, Shigehisa Kitano, Kinuko Tajima, et al.
Journal of Cancer Research and Clinical Oncology|July 31, 2017
Large-scale comprehensive immunohistochemical biomarker analyses in esophageal squamous cell carcinomaKen Hatogai, Satoshi Fujii, Takashi Kojima, et al.
NPJ Precision Oncology|January 15, 2025
Diversity of TCR repertoire predicts recurrence after CRT followed by durvalumab in patients with NSCLCMasayuki Shirasawa, Tatsuya Yoshida, Takaji Matsutani, et al.
Oncotarget|June 21, 2016
Comprehensive immunohistochemical analysis of tumor microenvironment immune status in esophageal squamous cell carcinomaKen Hatogai, Shigehisa Kitano, Satoshi Fujii, et al.
Cancer Science|February 22, 2021
First-in-human study of the cancer peptide vaccine TAS0313 in patients with advanced solid tumorsShunsuke Kondo, Toshio Shimizu, Takafumi Koyama, et al.
Oncotarget|October 21, 2016
Nivolumab for advanced melanoma: pretreatment prognostic factors and early outcome markers during therapyYoshio Nakamura, Shigehisa Kitano, Akira Takahashi, et al.
Journal of Immunological Methods|July 11, 2006
Generation of peptide-specific CD8+ T cells by phytohemagglutinin-stimulated antigen-mRNA-transduced CD4+ T cellsHiroaki Naota, Yoshihiro Miyahara, Satoshi Okumura, et al.
Oncotarget|September 30, 2016
Reduced argininosuccinate synthetase expression in refractory sarcomas: Impacts on therapeutic potential and drug resistanceYoungji Kim, Eisuke Kobayashi, Daisuke Kubota, et al.
Frontiers in Oncology|May 17, 2021
Case Report: A Case of Trimethoprim/Sulfamethoxazole-Triggered Hypotensive Shock: Cytokine Release Syndrome Related to Immune Checkpoint Inhibitors and Drug-Induced Hypersensitivity SyndromeTetsuya Urasaki, Makiko Ono, Toshiaki Mochizuki, et al.
Pageof 15

Showing results (41-50 of 150) with videos related to

Sort By:
Pageof 15
British Journal of Cancer|November 26, 2019
Relationship between the immune microenvironment of different locations in a primary tumour and clinical outcomes of oesophageal squamous cell carcinomaKen Hatogai, Satoshi Fujii, Shigehisa Kitano, et al.
International Journal of Hematology|October 24, 2019
Impact of low-dose anti-thymocyte globulin on immune reconstitution after allogeneic hematopoietic cell transplantationAyumu Ito, Shigehisa Kitano, Kinuko Tajima, et al.
Journal of Cancer Research and Clinical Oncology|July 31, 2017
Large-scale comprehensive immunohistochemical biomarker analyses in esophageal squamous cell carcinomaKen Hatogai, Satoshi Fujii, Takashi Kojima, et al.
NPJ Precision Oncology|January 15, 2025
Diversity of TCR repertoire predicts recurrence after CRT followed by durvalumab in patients with NSCLCMasayuki Shirasawa, Tatsuya Yoshida, Takaji Matsutani, et al.
Oncotarget|June 21, 2016
Comprehensive immunohistochemical analysis of tumor microenvironment immune status in esophageal squamous cell carcinomaKen Hatogai, Shigehisa Kitano, Satoshi Fujii, et al.
Cancer Science|February 22, 2021
First-in-human study of the cancer peptide vaccine TAS0313 in patients with advanced solid tumorsShunsuke Kondo, Toshio Shimizu, Takafumi Koyama, et al.
Oncotarget|October 21, 2016
Nivolumab for advanced melanoma: pretreatment prognostic factors and early outcome markers during therapyYoshio Nakamura, Shigehisa Kitano, Akira Takahashi, et al.
Journal of Immunological Methods|July 11, 2006
Generation of peptide-specific CD8+ T cells by phytohemagglutinin-stimulated antigen-mRNA-transduced CD4+ T cellsHiroaki Naota, Yoshihiro Miyahara, Satoshi Okumura, et al.
Oncotarget|September 30, 2016
Reduced argininosuccinate synthetase expression in refractory sarcomas: Impacts on therapeutic potential and drug resistanceYoungji Kim, Eisuke Kobayashi, Daisuke Kubota, et al.
Frontiers in Oncology|May 17, 2021
Case Report: A Case of Trimethoprim/Sulfamethoxazole-Triggered Hypotensive Shock: Cytokine Release Syndrome Related to Immune Checkpoint Inhibitors and Drug-Induced Hypersensitivity SyndromeTetsuya Urasaki, Makiko Ono, Toshiaki Mochizuki, et al.
Pageof 15